# NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)

> **NCT01331005** · PHASE2 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 125 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** nepafenac 0.1% drops
- **OTHER:** Nepafenac Vehicle

## Key facts

- **NCT ID:** NCT01331005
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331005, "NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01331005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*